Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 3 ... acceptance of the test and the clinical evidence supporting testing for levels of thromboxane metabolites in urine." Category I CPT codes are restricted to clinically ...
2009 OCT 12 ... in the dorsal skinfold chamber model. Prostacyclin [prostaglandin I(2) (PGI(2))] and thromboxane A(2) (TxA(2)) metabolites were measured. In vitro, endothelial adhesion molecule ...
2009 OCT 12 ... is a mediator of lung diseases and a potent pulmonary vasoconstrictor. In addition to thromboxane A2, it participates in the formation of lung edema." "Both lidocaine and ...
2009 OCT 12 ... The thrombin receptor protease activable receptor-1 antagonist SCH530348 and the thromboxane receptor antagonist terutroban are two promising agents that are now undergoing phase ...
2009 OCT 19 ... Platelet aggregation was monitored by measuring electric impedance, and the levels of thromboxane A2 (TXA(2)) and prostacyclin (PGI(2)) in blood were measured by I-125-TXB2 and ...
2009 NOV 2 ... mg once daily (period 2). All study medications were taken by mouth. Inhibition of serum thromboxane B-2 (TXB2), as a marker of platelet cyclooxygenase-1 (COX-1) inhibition, measured 24 h ...
2009 OCT 5 ... leukocyte adhesion, and platelet aggregation. In trauma the balance between PGI(2) and thromboxane A(2) (TXA(2)) is shifted towards TXA(2)," scientists writing in the Journal of ...
2009 OCT 12 ... Indomethacin, a non-selective cyclooxygenase (COX) inhibitor, and SQ29548, a selective thromboxane A(2) (TXA(2))/prostaglandin H(2) (PGH(2)) receptor antagonist prevented the reduction in ...
2009 NOV 23 ... dismutase in colonic mucosa, and decreased cyclooxygenase-2, prostaglandin E2 and thromboxane B2 levels. This study indicated that GSH suppressed the number of ACF, but the ...
2009 NOV 9 ... significantly more sensitive to PAN-induced injury, produced more prostaglandin E-2 and thromboxane B-2, and had greater expression of prostaglandin E2 receptor subtype 4 (EP4) and...
2009 OCT 5 ... with aspirin and a P2Y(12) adenosine diphosphate (ADP) receptor antagonist target the thromboxane A(2) and ADP pathways, respectively. Both can diminish activation by other factors, but ...
2009 NOV 9 ... functions of endothelium-derived NO [from (i) the absolute tension induced by epithio-thromboxane A(2) (STA(2)) or high K+; (ii) enhancement of the STA(2)-contraction by a nitric oxide ...
2009 OCT 5 ... also has proprietary pipeline programs focused on the discovery and development of a thromboxane receptor antagonist, which is targeted to address a significant unmet need as a ...
2009 NOV 17 ... 24 hours. Vasomotor function was studied using a myograph tension system in response to thromboxane A2 analog U46619, bradykinin and sodium nitroprusside (SNP). Superoxide anion production ...
2009 OCT 5 ... to collagen, ADP and arachidonic acid, and to urinary excretion of 11-dehydro thromboxane B2. Studies were conducted in 1600 individuals (45.0 +/- 12.9 years, 42.7% male) at risk ...
2009 OCT 5 ... phospholipids, and decreased the proinflammatory fatty acid arachidonic acid and urine thromboxane B-2 with both the standard and high-fat diet. Linoleic acid and tetralinoloyl ...
2009 NOV 16 ... According to a study from Szczecin, Poland, "Thromboxane (Tx) is a metabolite of arachidonic acid, which exerts a significant influence on kidney ...
2009 SEP 28 ... antiplatelet therapy may be due in part to incomplete inhibition of targeted pathways (thromboxane A(2) and adenosine diphosphate [ADP]) by currently available agents (aspirin and P2Y(12) ...
